Everything below concerns RP-HPLC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-06-23. Where a claim depends on a specific study, the study is described rather than over-claimed.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA under peptide hormones |
| WADA class | S2 | Peptide hormones, growth factors, related substances, and mimetics |
| Approved therapeutic use | Not established | Clinical research did not lead to broad marketing approval |
| Common detection method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| Sample preparation | Extraction and enrichment | Immunoaffinity or solid-phase extraction may be used |
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
== Clinical studies == PF-04455242 reached phase 1 clinical trials for bipolar depression prior to the discontinuation of its development in 2010. Its development was discontinued upon unfavorable toxicological findings in animals that had been exposed to the drug for 3 months. Along with JDTic, which was also discontinued due to toxicity findings early in clinical trials, PF-04455242 was one of the first KOR antagonists to be developed for potential treatment of psychiatric disorders. It was in phase 1 trials by 2009 and was first described in the scientific literature by 2010.
=== Pharmacodynamics === MDDMA shows reduced potency as a monoamine releasing agent and reuptake inhibitor compared to MDA and MDMA. It was 11-fold less potent than MDMA and 4-fold less potent than MDA as a serotonin releasing agent (SRA). Moreover, whereas MDA and MDMA are serotonin–norepinephrine–dopamine releasing agents (SNDRAs), MDDMA is a selective SRA along with ≥10-fold weaker dopamine and norepinephrine reuptake inhibition. The related drug MDTMA is completely inactive as a monoamine releasing agent, though it does still show very weak monoamine reuptake inhibition. Another related drug, dimethylamphetamine, is said to be a prodrug of methamphetamine and amphetamine, although it is much less potent and weaker than these drugs. (R)-MDDMA has been found be inactive as a serotonin releasing agent but to act as a partial agonist of the serotonin 5-HT2A and 5-HT2C receptors. Conversely, unlike MDMA, it was inactive as a serotonin 5-HT2B receptor agonist. In animal studies, (R)-MDDMA did not produce the head-twitch response, affect body temperature, or induce hyperlocomotion, and showed diminished or no prosocial effects. On the other hand, it produced psychoplastogenic effects mediated by serotonin 5-HT2 receptor activation as well as promoted fear extinction and induced antidepressant-like effects. It was concluded that (R)-MDDMA is a non-hallucinogenic psychoplastogen with improved safety compared to MDMA and (R)-MDMA.
== Athletic tracking and self-tracking uses == Hemoglobin can be tracked noninvasively, to build an individual data set tracking the hemoconcentration and hemodilution effects of daily activities for better understanding of sports performance and training. Athletes are often concerned about endurance and intensity of exercise. The sensor uses light-emitting diodes that emit red and infrared light through the tissue to a light detector, which then sends a signal to a processor to calculate the absorption of light by the hemoglobin protein. This sensor is similar to a pulse oximeter, which consists of a small sensing device that clips to the finger.
== Artery == The tunica media is made up of smooth muscle cells, elastic tissue, and collagen. It lies between the tunica intima on the inside and the tunica externa on the outside. The middle coat (tunica media) is distinguished from the inner (tunica intima) by its color and by the transverse arrangement of its fibers.
Ready to drink chocolate milk is produced by homogenization. At or below room temperature, chocolate is a solid, which does not dissolve, but instead remains a powdered solid suspended in milk. The suspension must be stabilized, otherwise, the powder will settle. Separation can be slowed by any of the following:
Sources: en.wikipedia.org
The Great Zimbabwe Bird first appeared in an armorial sense when it was incorporated in the coat of arms of Southern Rhodesia, which were granted by Royal Warrant on 11 August 1924. It was first used on a national flag when the full arms were displayed on the Rhodesian flag that was adopted on 11 November 1968. It then appeared alone on the Zimbabwe Rhodesian flag of 1979, and it is now displayed on the flag of Zimbabwe. The arms of 1924 were initially retained by the Zimbabwean Government until a new coat of arms were adopted on 12 September 1981. The Zimbabwe Bird depicted on the flag is rendered in the same format as it appeared on the arms of 1924 and as it appeared on the Rhodesian flag of 1968 and the Zimbabwe Rhodesian flag of 1979. The red star on which the bird is placed is a regular star. However, a different, rather flattened version of the bird, sometimes displayed on an irregular, flattened star, is often seen on flags that are manufactured outside of Zimbabwe. The origin of this discrepancy appears to be an illustration of the proposed new flag that was first released by the Zimbabwe Ministry of Information in April 1980, just prior to the country attaining full independence. This illustration showed the bird in a flattened version positioned over an irregular star.
=== Copper smelting === Exposure studies in the copper smelting industry are much more extensive and have established definitive links between arsenic, a by-product of copper smelting, and lung cancer via inhalation. Dermal and neurological effects were also increased in some of these studies. Although further occupational controls were introduced and workers were exposed to lower arsenic concentrations, the arsenic exposures measured in these studies range from about 0.05 to 0.3 mg/m3, significantly higher than usual airborne levels, ranging from 0 to 0.000003 mg/m3).
=== Ubiquitination of non-protein substrates === Although ubiquitination was historically considered a protein-specific post-translational modification, recent studies have shown that ubiquitin can also be conjugated to certain non-protein molecules. These include lipopolysaccharides (LPS), phospholipids and other metabolites. A notable example is the E3 ligase RNF213 which can attach ubiquitin to the lipid A moiety of bacterial LPS, promoting xenophagic clearance of invading bacteria. These findings expand the known scope of ubiquitin signaling beyond classical post-translational protein modification.
Sanders later described his time in Chicago as "the major period of intellectual ferment in my life." While there, he joined the Young People's Socialist League (the youth affiliate of the Socialist Party of America) and was active in the civil rights movement as a student for the Congress of Racial Equality (CORE) and the Student Nonviolent Coordinating Committee (SNCC). Under his chairmanship, the university chapter of CORE merged with the university chapter of the SNCC. In January 1962, he went to a rally at the University of Chicago administration building to protest university president George Wells Beadle's segregated campus housing policy. At the protest, Sanders said, "We feel it is an intolerable situation when Negro and white students of the university cannot live together in university-owned apartments." He and 32 other students then entered the building and camped outside the president's office. After weeks of sit-ins, Beadle and the university formed a commission to investigate discrimination. After further protests, the University of Chicago ended racial segregation in private university housing in the summer of 1963. Joan Mahoney, a member of the University of Chicago CORE chapter at the time and a fellow participant in the sit-ins, described Sanders in a 2016 interview as "a swell guy, a nice Jewish boy from Brooklyn, but he wasn't terribly charismatic.
Sources: en.wikipedia.org
=== Subdivision === Traditionally Rhodiola was divided into subgenera, sections and series, based on plant characteristics. Four subgenera were recognised; Rhodiola, Primuloides, Crassipedes and Clementsia. However molecular studies have failed to demonstrate monophyly of these subtaxa.
=== Cardiac stress testing === Cardiac stress testing is used to determine to assess cardiac function and to disclose evidence of exertion-related cardiac hypoxia. Radionuclide testing using thallium or technetium can be used to demonstrate areas of perfusion abnormalities. With a maximal stress test the level of exercise is increased until the person's heart rate will not increase any higher, despite increased exercise. A fairly accurate estimate of the target heart rate, based on extensive clinical research, can be estimated by the formula 220 beats per minute minus patient's age. This linear relation is accurate up to about age 30, after which it mildly underestimates typical maximum attainable heart rates achievable by healthy individuals. Other formulas exist, such as that by Miller (217 - (0.85 × Age)) and others. Achieving a high enough heart rate at the end of exercise is critical to improving the sensitivity of the test to detect high grade heart artery stenosis. High frequency analysis of the QRS complex may be useful for detection of coronary artery disease during an exercise stress test.
=== Post-World War II period === The federation and football overall was disrupted by World War II. After the war, a socialist federation was formed and the football federation reconstituted. It was one of the founding members of the UEFA in 1954.
Sources: en.wikipedia.org
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.
Confirmatory detection typically uses liquid chromatography with mass spectrometry. Immunoassays may be used for screening, but mass spectrometry provides structural confirmation.
No widely approved therapeutic indication exists for AOD-9604. It has been investigated in clinical studies, but regulatory approvals for general medical use are not established.
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.